x min read

Morning Buz: JPMorgan Chase & Co. (NYSE:JPM), Pfizer Inc. (NYSE:PFE), ManpowerGroup Inc. (NYSE:MAN), Harvard Bioscience Inc. (NASDAQ:HBIO), 58.com Inc. (NYSE:WUBA)

Morning Buz: JPMorgan Chase & Co. (NYSE:JPM), Pfizer Inc. (NYSE:PFE), ManpowerGroup Inc. (NYSE:MAN), Harvard Bioscience Inc. (NASDAQ:HBIO), 58.com Inc. (NYSE:WUBA)
Written by
Charles Donlon
Published on
November 14, 2014
Copy URL
Share on LinkedIn
Share on Reddit
Share on Twitter/X
Share on Facebook
InsidrFinancial

JPMorgan Chase & Co. (NYSE:JPM)’s Insider Mark O’donovan unloaded 1,144 shares of JPMorgan Chase & Co. stock in a transaction that occurred on Friday, October 31st. The stock was sold at an average price of $60.26, for a total value of $68,937.44. JPMorgan Chase & Co. (NYSE:JPM) belongs to Financial sector. Its net profit margin is 39.60% and weekly performance is -1.63%. On last trading day company shares ended up $60.23. JPMorgan Chase & Co. (NYSE:JPM) distance from 50-day simple moving average (SMA50) is 1.35%. Pfizer Inc (NYSE:PFE) and the Bill & Melinda Gates Foundation on Thursday announced an agreement to expand access to the drugmaker's long-acting Sayana Press contraceptive to women in 69 of the world's poorest countries, for $1 per dose. Pfizer Inc. (NYSE:PFE) belongs to Healthcare sector. Its net profit margin is 64.40% and weekly performance is 1.26%. On last trading day company shares ended up $30.42. Pfizer Inc. (NYSE:PFE) distance from 50-day simple moving average (SMA50) is 4.14%. ManpowerGroup Inc. (NYSE:MAN)’s Director John R. Walter unloaded 3,588 shares of the company’s stock in a transaction dated Monday, October 27th. The shares were sold at an average price of $63.83, for a total transaction of $229,022.04. On 13 November, ManpowerGroup Inc. (NYSE:MAN) shares fell -2.35% and was closed at $65.65. MAN EPS growth in last 5 year was 7.00%. ManpowerGroup Inc. (NYSE:MAN) year to date (YTD) performance is -23.08%. Harvard Bioscience, Inc. (NASDAQ:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, has appointed Bertrand Loy to its Board of Directors, effective immediately. Mr. Loy is President and CEO of Entegris Inc., a provider of yield-enhancing materials and solutions used in advanced high-tech manufacturing environments. He earlier served as Chief Operating Officer and Chief Administrative Officer of Entegris; under his leadership he helped grow the company's revenue to $1.1 billion. He previously worked as Chief Financial Officer of Mykrolis Corp., the former microelectronics division of Millipore. Prior to this, he was with Millipore initially as the Director of Finance and Manufacturing for Millipore's Laboratory Water Division before moving to the position of Chief Information Officer. Harvard Bioscience Inc. (NASDAQ:HBIO) ended the last trading day at $4.84. Company weekly volatility is calculated as 3.17% and price to cash ratio as 5.88. Harvard Bioscience Inc. (NASDAQ:HBIO) showed a weekly performance of 4.54%. 58.Com Inc. (NYSE:WUBA) rose the most since June in New York as the Chinese classified advertising website reported earnings that exceeded analysts’ estimates and forecast as much as a 70 percent increase in fourth-quarter revenue. 58.com Inc. (NYSE:WUBA) shares fell -2.82% in last trading session and ended the day at $44.82. WUBA Gross Margin is 94.90% and its return on assets is 5.60%. 58.com Inc. (NYSE:WUBA) quarterly performance is -10.31%.

Discover Hidden Gems

Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.